Serdar Yamanyar

Serdar Yamanyar

Auto-generated profile, based on publicly available information

Serdar Yamanyar


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
EUEmel Uyar
Emel Uyar
AMAlparslan Merdin
Alparslan Merdin
SYSerdar Yamanyar
Serdar Yamanyar
MEMehmet Can Ezgu
Mehmet Can Ezgu
CACumhur Artuk
Cumhur Artuk
SCSerkan Ceri̇tLi̇
Serkan Ceri̇tLi̇
Creating potential clinical markers for risk assessment in patients with COVID-19 continues to be an area of interest. In this study, we aimed to evaluate whether serum albumin level and thrombocyte/lymphocyte ratio are related to the severity of the disease. The patients were divided into two groups according to the severity of disease. Demographic data, serum albumin value, lymphocyte count, TLO-1 values (thrombocyte/lymphocyte ratio-1), the highest thrombocyte count during hospitalization, TLO-2 (thrombocyte/lymphocyte ratio-2) values formed by the highest thrombocyte count, was recorded. There was no statistically significant differences (p> 0.05) in terms of gender, thrombocyte count at the time of admission, and highest thrombocyte count during hospital follow-up. There were statistically significant differences in terms of age, comorbidity, lymphocyte value at the time of hospitalization, lymphocyte count during hospital follow-up, TLO I, TLO II, and serum albumin values between the groups. In the ICU group were found to be older, had higher rates of comorbidity, lower lymphocyte values, higher TLO I- II, and lower serum albumin levels (P <0.05) Conclusions: TLO-2 ratio above 260 and lymphocyte level below 1x 103cells/uL, would be a predictor of further intensive care unit need.

27 May 2024
Verified
Book
Open access
PDF file
HDHayriye Cankar Dal
Hayriye Cankar Dal
EYEsra YAKIŞIK
Esra YAKIŞIK
AKAyse Muge Karcioglu
Ayse Muge Karcioglu
ITIşıl Ozkocak Turan
Işıl Ozkocak Turan
MYMehmet Eren Yuksel
Mehmet Eren Yuksel
IMİbRahim Mungan
İbRahim Mungan
Akut Böbrek Hasarı Tanımı ve Patofizyolojisi Hayriye CANKAR DAL Akut Böbrek Hasarı Biyobelirteçleri Esra YAKIŞIK ÇAKIR Akut Böbrek Hasarında Renal Koruma Ayşe Müge KARCIOĞLU Işıl ÖZKOÇAK TURAN Akut Böbrek Hasarının Yönetimi ve Renal Replasman Tedavisi Dışındaki Tedavi Yöntemleri Mehmet Eren YÜKSEL Ahmet Gökhan AKDAĞ Sürekli Renal Replasman Tedavisi Tarihçesi Derya GÖKÇINAR Fizyolojik Prensipler ve Terminoloji Büşra TEZCAN Cihazın Yapısı ve Bileşenleri Sema TURAN Çilem BAYINDIR DİCLE Sürekli Renal Replasman Tedavisinde Kullanılan Membran ve Filtreler Tülay TUNÇER PEKER Sevil BALTACI ÖZEN Sürekli Renal Replasman Tedavisinde Kullanılan Tampon Solüsyonlar Belgin AKAN Kurulum Behiye Deniz KOSOVALI Sürekli Renal Replasman Tedavisinde Gösterge ve Alarmlar Serdar YAMANYAR Sürekli Renal Replasman Tedavisinde Vasküler Erişim Yolları Berkay KÜÇÜK Belgin AKAN Sürekli Renal Replasman Tedavisi Endikasyonları ve Zamanlama Mete ERDEMİR Sercan YILMAZ Levent YAMANEL Tedavi Modalitesi Seçimi Dilek ÖZTÜRK KAZANCI Müçteba CAN Dozun Belirlenmesi ve Reçeteleme Hasan DİRİK Demet BÖLÜKBAŞI Rejyonel Sitrat Antikoagülasyonu Mehmet Eren YÜKSEL Seval İZDEŞ Sitrat Dışı Antikoagülasyon Baha Burak KONAK Seval İZDEŞ Hasta Monitörizasyonu ve Sonlandırma Kararı Mahmut YILMAZ Gürhan TAŞKIN Sürekli Renal Replasman Tedavisinin Komplikasyonları Şerife GÖKBULUT BEKTAŞ Ahmet Bilal KANDEMİR Sepsis ve SRRT Dilek ÖZTÜRK KAZANCI Sema SARI Sürekli Renal Replasman Tedavisinde Sıvı Yönetimi Cihangir DOĞU Beslenme ve Sürekli Renal Replasman Tedavisi Deniz ERDEM ECMO Uygulanan Hastada SRRT Sema TURAN İbrahim MUNGAN İlaç Uygulamaları ve SRRT Tülay TUNÇER PEKER Sürekli Renal Replasman Tedavisinin Ekstrarenal Endikasyonları Baha Burak KONAK Seval İZDEŞ Çoklu Organ Destek Tedavisi Derya GÖKÇINAR


3 September 2019 in The European Research Journal
Verified
Journal Article
Open access
IMİbRahim Mungan
İbRahim Mungan
STSema Turan
Sema Turan
DKDilek Kazancı
Dilek Kazancı
HDHayriye Cankar Dal
Hayriye Cankar Dal
SYSerdar Yamanyar
Serdar Yamanyar
EBErdal Birol Bostancı
Erdal Birol Bostancı
Objectives: The individual risk of surgical patients is more often underestimated and < 15% of patients who underwent surgery were admitted to ICU. The prognostic scores were developed to assess the mortality rate and prognosis for critical patients including surgical ones. The Acute Physiology and Chronic Health Evaluation (APACHE) score and the Simplified Acute Physiology Score (SAPS) were most popular ones and they were revised with the improvements in health care opportunities. As a prognostic scoring system SAPS 3’ results were defined as excellent in high risk surgical patient study group. CRP is useful as a prognostic indicator or an index of disease progression but its value has not been tested in acute settings adequately. The aim of this study is to test the calibration power of SAPS 3 score and identify correlations between hospital mortality and patient outcomes with SAPS 3 scores and CRP levels.Methods: This retrospective and analytical study was conducted one year period in surgical ICUs of tertiary level of attention in a public institution. It was a case–control medical record review and the patients included in this study were those who admitted in the surgical ICU for any reason.Results: A total of 806 patients admitted to the Gastroenterological surgical ICU was included in the study between March 2016 and March 2017. The relation between mortality rate, length of stay in ICU and SAPS 3 score was significant statistically and the relation of CRP levels with SAPS score and mortality rate was found significant statistically. Conclusion: The discriminative power of SAPS 3 score was very good and the calibration was appropriate.